Eloxx Pharmaceuticals, Inc. ELOX

Set alert

Price alert · ELOX

All alert types
13.45 USD +0.27 +2.05%

At close · Oct 30

13.90 +0.45 +3.35%

After hours · Oct 30, 4:00 PM ET

Bid
13.23 × 2
Ask
13.69 × 1
12.99 Day range 13.77
10.95 52-week range 20.98
YTD
+22.16%
1 year
+22.16%
Open
13.35
Prev close
13.18
Mkt cap
54.29M
Vol
13.99K
Avg vol
34.36K
EPS
3.52
P/E
3.82
Div yield
0.00%
More statistics
Low
12.99
High
13.77
Forward P/E
-0.87
Beta
2.61
Short ratio
0.63
Inst. own
43.97%
Dividend
0.00
Ex-div date
Earnings
Dec 23, 2024
50-d avg
6.06
200-d avg
5.01
1y target
55.00

5D chart

Chart tools
Interval

Signals (23)
NameTimeAgo
SMA: BullishOct 30, 3:55 PM1 day ago
SMA: BearishOct 30, 2:35 PM1 day ago
SMA: BullishOct 29, 3:55 PM2 days ago
MACD: Buy SignalOct 29, 3:55 PM2 days ago
SMA: BullishOct 29, 3:50 PM2 days ago
SMA: BearishOct 29, 12:35 PM2 days ago
SMA: BearishOct 29, 12:35 PM2 days ago
MACD: Sell SignalOct 29, 12:35 PM2 days ago
SMA: BullishOct 29, 11:45 AM2 days ago
SMA: BearishOct 29, 11:40 AM2 days ago
SMA: BullishOct 29, 10:20 AM2 days ago
SMA: BearishOct 28, 2:55 PM3 days ago
SMA: BullishOct 28, 2:40 PM3 days ago
SMA: BullishOct 28, 2:40 PM3 days ago
SMA: BearishOct 28, 2:25 PM3 days ago
SMA: BearishOct 28, 2:25 PM3 days ago
SMA: BullishOct 28, 12:35 PM3 days ago
SMA: BullishOct 28, 12:35 PM3 days ago
SMA: BearishOct 28, 11:55 AM3 days ago
SMA: BearishOct 28, 11:55 AM3 days ago
SMA: BullishOct 27, 2:55 PM4 days ago
SMA: BearishOct 27, 9:40 AM4 days ago
SMA: BullishOct 26, 2:35 PM5 days ago

Discussion (14)

Sign in to join the discussion

Bull ELOX 2 years ago #2

Very positive news

VICKY HANUKA ELOX 3 years ago #3

?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi

-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for 
$1.0 billion upfront 
-- PTC Therapeutics has option to sell rest of royalty for up to $500 
million; Royalty Pharma has option to buy half of rest of royalty for up 
to $250 million 
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth 
(non-GAAP) 
-- Royalty Pharma to host conference call today, Thursday, October 19 at 
9:00am EDT 
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

Scott Miller ELOX 3 years ago #5

$ELOX sell in may, go away. Low buys in september are the ones to remember. ;-)

Bull ELOX 3 years ago #6

Volume past 2 days has been much much greater than previous candles. Something is cooking.

Scott Miller ELOX 3 years ago #8

$ELOX perhaps the secondary offering is almost complete. By reg, since the float is about 2.1m shares, only about 700k can be sold at this point(one third of the public float). Since the filing on May 15th, stock price $8.59 on the close, I calculate about 1.5m shares have traded to date. Oppenheimer might be done?

Bull ELOX 3 years ago #9

Excellent detailed presentation $ELOX

Bull ELOX 3 years ago #10

Going to spike soon. 18 EOM